Status:

UNKNOWN

Inverted Flap Versus Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes

Lead Sponsor:

University of Turin, Italy

Conditions:

Full Thickness Macular Hole

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Primary outcome: difference of microperimetry retinal sensitivity after primary vitrectomy for idiopathic full thickness macular holes with inverted flap technique versus internal limiting membrane (I...

Eligibility Criteria

Inclusion

  • \>18 years old
  • idiopathic full thickness macular hole ≤ 350 micron of diameter
  • phakic or pseudophakic
  • absence of systemic adverse conditions

Exclusion

  • concomitant retinal and other ocular disease
  • previous ocular surgery except cataract surgery
  • axial length \>26mm

Key Trial Info

Start Date :

May 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04498624

Start Date

May 1 2020

End Date

May 1 2021

Last Update

August 4 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

A.O.U. Città della Salute e della Scienza di Torino

Torino, Italy, 10126